Particle.news

Download on the App Store

Medical Community Rebuts White House Tylenol–Autism Claim, Citing Risks of Withholding Care in Pregnancy

Leading obstetrics groups point to robust studies finding no causal link, maintaining guidance to use acetaminophen judiciously in pregnancy.

Overview

  • President Donald Trump publicly urged pregnant women to avoid acetaminophen, asserting an association with autism that major medical organizations say is unsupported by causal evidence.
  • A large JAMA study led by Drexel’s Brian Lee found that, after sibling comparisons to account for familial factors, there was no association between maternal acetaminophen use and autism.
  • Health and Human Services announced a $50 million Autism Data Science Initiative, and the administration said the FDA would approve leucovorin for autistic children, positions scientists and clinicians viewed as outpacing established evidence.
  • The Society for Maternal-Fetal Medicine and ACOG continue to recommend acetaminophen for fever and pain in pregnancy because untreated symptoms can endanger the fetus, especially early in gestation.
  • Advocates warn that the administration’s messaging could feed punitive approaches to pregnancy, noting a report of more than 400 prosecutions for pregnancy-related offenses in the two years since Dobbs, and clinicians caution against substituting ibuprofen due to documented pregnancy risks.